Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Sees Significant Growth in Short Interest

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 4,010,000 shares, an increase of 11.1% from the May 31st total of 3,610,000 shares. Based on an average daily volume of 860,300 shares, the short-interest ratio is presently 4.7 days.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $67.01 on Tuesday. The business’s 50 day moving average price is $68.38 and its two-hundred day moving average price is $75.79. The company has a market cap of $6.22 billion, a PE ratio of -478.61, a price-to-earnings-growth ratio of 2.03 and a beta of 1.31. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.63. Acadia Healthcare has a twelve month low of $62.04 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The firm had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business’s revenue was up 9.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.75 earnings per share. On average, analysts predict that Acadia Healthcare will post 3.52 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its position in shares of Acadia Healthcare by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after purchasing an additional 30,296 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Acadia Healthcare by 2.1% in the third quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock valued at $529,991,000 after purchasing an additional 152,783 shares during the last quarter. Avidity Partners Management LP boosted its stake in shares of Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after buying an additional 441,692 shares during the period. Jennison Associates LLC boosted its stake in shares of Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after buying an additional 238,114 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Acadia Healthcare by 3.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,035,114 shares of the company’s stock valued at $80,490,000 after buying an additional 38,410 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a report on Thursday, April 25th. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Bank of America cut their price target on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Barclays lowered their target price on Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 15th. Finally, TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $87.56.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.